Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C

Splenic venous thrombosis is a rare disease in which an underlying hypercoagulable state can often be found. A 27-years old female patient with recurrent mesenteric venous and splenic thrombosis as a severe complication of an association of resistance to activated protein C and essential thrombocyth...

Full description

Bibliographic Details
Main Authors: Marisavljević Dragomir, Elezović Ivo V., Bilanović Dragoljub, Petrović Nataša, Janjić Mirjana, Šefer Dijana
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2003-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500302227M.pdf
id doaj-c9c4e18770e5484a9b42441c95e9adc1
record_format Article
spelling doaj-c9c4e18770e5484a9b42441c95e9adc12020-11-25T00:35:49ZengMilitary Health Department, Ministry of Defance, SerbiaVojnosanitetski Pregled0042-84502003-01-0160222723110.2298/VSP0302227MMesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein CMarisavljević DragomirElezović Ivo V.Bilanović DragoljubPetrović NatašaJanjić MirjanaŠefer DijanaSplenic venous thrombosis is a rare disease in which an underlying hypercoagulable state can often be found. A 27-years old female patient with recurrent mesenteric venous and splenic thrombosis as a severe complication of an association of resistance to activated protein C and essential thrombocythemia is presented in this report. Establishing the diagnosis of essential thrombocytosis was particularly difficult because this was the case of the so called "silent" myeloproliferative disorder. The number of thrombocytes was almost normal before the splenectomy performed because of the splenic venous thrombosis. Thus, spontaneous growth of erythroid and megakaryocyte colonies in vitro and the clinical course of the disease were the clues for establishing the diagnosis, because the number of thrombocytes reached the values over 1500×109/l after only 1.5 years of the follow-up. The case of this patient was interesting particularly from the surgical point of view because of the management strategy.http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500302227M.pdfthrombosismesenteric veinssplenic veinthrombocytosisthrombophiliaactivated protein C resistanceblood platelets
collection DOAJ
language English
format Article
sources DOAJ
author Marisavljević Dragomir
Elezović Ivo V.
Bilanović Dragoljub
Petrović Nataša
Janjić Mirjana
Šefer Dijana
spellingShingle Marisavljević Dragomir
Elezović Ivo V.
Bilanović Dragoljub
Petrović Nataša
Janjić Mirjana
Šefer Dijana
Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
Vojnosanitetski Pregled
thrombosis
mesenteric veins
splenic vein
thrombocytosis
thrombophilia
activated protein C resistance
blood platelets
author_facet Marisavljević Dragomir
Elezović Ivo V.
Bilanović Dragoljub
Petrović Nataša
Janjić Mirjana
Šefer Dijana
author_sort Marisavljević Dragomir
title Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
title_short Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
title_full Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
title_fullStr Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
title_full_unstemmed Mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein C
title_sort mesenteric and splenic venous thrombosis in a female patient with essential thrombocytosis and the resistance to activated protein c
publisher Military Health Department, Ministry of Defance, Serbia
series Vojnosanitetski Pregled
issn 0042-8450
publishDate 2003-01-01
description Splenic venous thrombosis is a rare disease in which an underlying hypercoagulable state can often be found. A 27-years old female patient with recurrent mesenteric venous and splenic thrombosis as a severe complication of an association of resistance to activated protein C and essential thrombocythemia is presented in this report. Establishing the diagnosis of essential thrombocytosis was particularly difficult because this was the case of the so called "silent" myeloproliferative disorder. The number of thrombocytes was almost normal before the splenectomy performed because of the splenic venous thrombosis. Thus, spontaneous growth of erythroid and megakaryocyte colonies in vitro and the clinical course of the disease were the clues for establishing the diagnosis, because the number of thrombocytes reached the values over 1500×109/l after only 1.5 years of the follow-up. The case of this patient was interesting particularly from the surgical point of view because of the management strategy.
topic thrombosis
mesenteric veins
splenic vein
thrombocytosis
thrombophilia
activated protein C resistance
blood platelets
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2003/0042-84500302227M.pdf
work_keys_str_mv AT marisavljevicdragomir mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
AT elezovicivov mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
AT bilanovicdragoljub mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
AT petrovicnatasa mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
AT janjicmirjana mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
AT seferdijana mesentericandsplenicvenousthrombosisinafemalepatientwithessentialthrombocytosisandtheresistancetoactivatedproteinc
_version_ 1725307490036350976